SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-20-000069
Filing Date
2020-11-05
Accepted
2020-11-05 12:18:18
Documents
77
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20200930.htm   iXBRL 10-Q 1767727
2 EX-31.1 exhibit31-1x09x30x20.htm EX-31.1 9872
3 EX-31.2 exhibit31-2x09x30x20.htm EX-31.2 9874
4 EX-32.1 exhibit32-1x09x30x20.htm EX-32.1 4869
5 EX-32.2 exhibit32-2x09x30x20.htm EX-32.2 4872
  Complete submission text file 0001439222-20-000069.txt   7158510

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20200930.xsd EX-101.SCH 58254
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20200930_cal.xml EX-101.CAL 88275
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20200930_def.xml EX-101.DEF 225013
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20200930_lab.xml EX-101.LAB 532030
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20200930_pre.xml EX-101.PRE 398051
11 EXTRACTED XBRL INSTANCE DOCUMENT agio-20200930_htm.xml XML 1244999
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 201289461
SIC: 2834 Pharmaceutical Preparations